These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37182303)

  • 1. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria.
    Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C
    Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006-2008.
    Siwakoti RC; Cathey A; Ferguson KK; Hao W; Cantonwine DE; Mukherjee B; McElrath TF; Meeker JD
    Environ Res; 2023 Nov; 237(Pt 2):116967. PubMed ID: 37634691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
    Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
    Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
    Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
    Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
    Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
    Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and polyfluoroalkyl substances (PFAS) and fetal growth: A nation-wide register-based study on PFAS in drinking water.
    Säve-Söderbergh M; Gyllenhammar I; Schillemans T; Lindfeldt E; Vogs C; Donat-Vargas C; Halldin Ankarberg E; Glynn A; Ahrens L; Helte E; Åkesson A
    Environ Int; 2024 May; 187():108727. PubMed ID: 38735074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Gestational Exposure to Individual and Combined Per- and Polyfluoroalkyl Substances on a Placental Structure and Efficiency: Findings from the Ma'anshan Birth Cohort.
    Gan H; Xing Y; Tong J; Lu M; Yan S; Huang K; Wu X; Tao S; Gao H; Pan Y; Dai J; Tao F
    Environ Sci Technol; 2024 Apr; 58(14):6117-6127. PubMed ID: 38525964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
    Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
    Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Maternal Stress, Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFAS), and Demographic Risk Factors with Birth Outcomes and Offspring Neurodevelopment: An Overview of the ECHO.CA.IL Prospective Birth Cohorts.
    Eick SM; Enright EA; Geiger SD; Dzwilewski KLC; DeMicco E; Smith S; Park JS; Aguiar A; Woodruff TJ; Morello-Frosch R; Schantz SL
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extractable Organofluorine Analysis in Pooled Human Serum and Placental Tissue Samples from an Austrian Subpopulation-A Mass Balance Analysis Approach.
    Kaiser AM; Forsthuber M; Aro R; Kärrman A; Gundacker C; Zeisler H; Foessleitner P; Salzer H; Hartmann C; Uhl M; Yeung LWY
    Environ Sci Technol; 2021 Jul; 55(13):9033-9042. PubMed ID: 34133125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Per- and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: A systematic review and meta-analysis.
    Gao X; Ni W; Zhu S; Wu Y; Cui Y; Ma J; Liu Y; Qiao J; Ye Y; Yang P; Liu C; Zeng F
    Environ Res; 2021 Oct; 201():111632. PubMed ID: 34237336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.